Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New radiation method aims to shrink large tumors

NCT ID NCT07647679

First seen Jun 15, 2026 · Last updated Jun 23, 2026 · Updated 2 times

Summary

This pilot study tests whether adding a specialized radiation technique called Lattice Radiation Therapy (LRT) to standard palliative radiation can safely shrink large tumors (at least 4.5 cm) in adults. The study will enroll 25 people with various cancers who are already scheduled for palliative radiation. Participants receive one extra LRT treatment before starting standard radiation, and researchers will monitor side effects and tumor shrinkage for one year.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PALLIATIVE RADIOTHERAPY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Duke Cancer Center

    Durham, North Carolina, 27710, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Lattice Radiation Therapy (LRT)

What this could lead to

If it works, this could offer a new way to shrink large tumors that are hard to treat with standard radiation alone.

What could go wrong

This is a very small pilot study (25 people) with no control group, so results may not apply broadly. It only tests safety and early effectiveness, not a proven treatment.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.